CN112680498A - High-throughput screening method for genotoxic substances - Google Patents
High-throughput screening method for genotoxic substances Download PDFInfo
- Publication number
- CN112680498A CN112680498A CN202011581900.1A CN202011581900A CN112680498A CN 112680498 A CN112680498 A CN 112680498A CN 202011581900 A CN202011581900 A CN 202011581900A CN 112680498 A CN112680498 A CN 112680498A
- Authority
- CN
- China
- Prior art keywords
- escherichia coli
- gene
- recombinant
- throughput screening
- survival rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 230000001738 genotoxic effect Effects 0.000 title claims abstract description 23
- 238000013537 high throughput screening Methods 0.000 title claims abstract description 21
- 231100000024 genotoxic Toxicity 0.000 title claims abstract description 14
- 239000000126 substance Substances 0.000 title claims abstract description 14
- 241000588724 Escherichia coli Species 0.000 claims abstract description 94
- 238000001514 detection method Methods 0.000 claims abstract description 61
- 239000013598 vector Substances 0.000 claims abstract description 27
- 231100000025 genetic toxicology Toxicity 0.000 claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 101710102974 O-acetyl transferase Proteins 0.000 claims abstract description 15
- 108020001162 nitroreductase Proteins 0.000 claims abstract description 15
- 108700026220 vif Genes Proteins 0.000 claims abstract description 11
- 231100000277 DNA damage Toxicity 0.000 claims abstract description 9
- 230000005778 DNA damage Effects 0.000 claims abstract description 9
- 102000004459 Nitroreductase Human genes 0.000 claims abstract description 9
- 108091027981 Response element Proteins 0.000 claims abstract description 9
- 230000009089 cytolysis Effects 0.000 claims abstract description 9
- 239000013604 expression vector Substances 0.000 claims abstract description 5
- 230000004083 survival effect Effects 0.000 claims description 38
- 239000000575 pesticide Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 13
- 230000001580 bacterial effect Effects 0.000 claims description 12
- XFOHWECQTFIEIX-UHFFFAOYSA-N 2-nitrofluorene Chemical compound C1=CC=C2C3=CC=C([N+](=O)[O-])C=C3CC2=C1 XFOHWECQTFIEIX-UHFFFAOYSA-N 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 9
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- -1 tert-butyl sulfenyl Chemical group 0.000 claims description 5
- 239000012880 LB liquid culture medium Substances 0.000 claims description 4
- 238000002835 absorbance Methods 0.000 claims description 4
- 230000002068 genetic effect Effects 0.000 claims description 4
- 231100000167 toxic agent Toxicity 0.000 claims description 4
- 239000003440 toxic substance Substances 0.000 claims description 4
- RJKGJBPXVHTNJL-UHFFFAOYSA-N 1-nitronaphthalene Chemical compound C1=CC=C2C([N+](=O)[O-])=CC=CC2=C1 RJKGJBPXVHTNJL-UHFFFAOYSA-N 0.000 claims description 3
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 claims description 3
- CUARLQDWYSRQDF-UHFFFAOYSA-N 5-Nitroacenaphthene Chemical compound C1CC2=CC=CC3=C2C1=CC=C3[N+](=O)[O-] CUARLQDWYSRQDF-UHFFFAOYSA-N 0.000 claims description 3
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 claims description 3
- 239000005660 Abamectin Substances 0.000 claims description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims description 3
- 239000005867 Iprodione Substances 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 239000005591 Pendimethalin Substances 0.000 claims description 3
- 239000005663 Pyridaben Substances 0.000 claims description 3
- 241001052560 Thallis Species 0.000 claims description 3
- 239000005941 Thiamethoxam Substances 0.000 claims description 3
- 239000005843 Thiram Substances 0.000 claims description 3
- 229950008167 abamectin Drugs 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 238000005336 cracking Methods 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 claims description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229960001952 metrifonate Drugs 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- CHIFOSRWCNZCFN-UHFFFAOYSA-N pendimethalin Chemical compound CCC(CC)NC1=C([N+]([O-])=O)C=C(C)C(C)=C1[N+]([O-])=O CHIFOSRWCNZCFN-UHFFFAOYSA-N 0.000 claims description 3
- 150000002989 phenols Chemical class 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 claims description 3
- 229960002447 thiram Drugs 0.000 claims description 3
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 claims description 3
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 claims description 2
- 239000005946 Cypermethrin Substances 0.000 claims description 2
- 239000005891 Cyromazine Substances 0.000 claims description 2
- 239000005906 Imidacloprid Substances 0.000 claims description 2
- 239000011717 all-trans-retinol Substances 0.000 claims description 2
- 150000001448 anilines Chemical class 0.000 claims description 2
- 239000006013 carbendazim Substances 0.000 claims description 2
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 claims description 2
- 229960005424 cypermethrin Drugs 0.000 claims description 2
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 claims description 2
- 229950000775 cyromazine Drugs 0.000 claims description 2
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 claims description 2
- 229940056881 imidacloprid Drugs 0.000 claims description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 230000031700 light absorption Effects 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 claims 1
- ARAFHJWYEUNRII-UHFFFAOYSA-N 5-nitroacenaphthylene Chemical group C1=CC2=CC=CC3=C2C1=CC=C3[N+](=O)[O-] ARAFHJWYEUNRII-UHFFFAOYSA-N 0.000 claims 1
- 230000002101 lytic effect Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 239000000049 pigment Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 22
- 230000007674 genetic toxicity Effects 0.000 description 11
- 238000003776 cleavage reaction Methods 0.000 description 9
- 230000007017 scission Effects 0.000 description 9
- 238000011144 upstream manufacturing Methods 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 101150071732 nhoA gene Proteins 0.000 description 6
- 150000002828 nitro derivatives Chemical class 0.000 description 6
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 101100079427 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) nat gene Proteins 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 3
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000008794 genotoxic response Effects 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- LNMBCRKRCIMQLW-UHFFFAOYSA-N 2-tert-butylsulfanyl-2-methylpropane Chemical compound CC(C)(C)SC(C)(C)C LNMBCRKRCIMQLW-UHFFFAOYSA-N 0.000 description 1
- GFBLJMHGHAXGNY-ZLUOBGJFSA-N Ala-Asn-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GFBLJMHGHAXGNY-ZLUOBGJFSA-N 0.000 description 1
- FOWHQTWRLFTELJ-FXQIFTODSA-N Ala-Asp-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N FOWHQTWRLFTELJ-FXQIFTODSA-N 0.000 description 1
- RXTBLQVXNIECFP-FXQIFTODSA-N Ala-Gln-Gln Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RXTBLQVXNIECFP-FXQIFTODSA-N 0.000 description 1
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- BLIMFWGRQKRCGT-YUMQZZPRSA-N Ala-Gly-Lys Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN BLIMFWGRQKRCGT-YUMQZZPRSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 1
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 1
- VHEVVUZDDUCAKU-FXQIFTODSA-N Ala-Met-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O VHEVVUZDDUCAKU-FXQIFTODSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 1
- JNJHNBXBGNJESC-KKXDTOCCSA-N Ala-Tyr-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JNJHNBXBGNJESC-KKXDTOCCSA-N 0.000 description 1
- XKHLBBQNPSOGPI-GUBZILKMSA-N Ala-Val-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)N XKHLBBQNPSOGPI-GUBZILKMSA-N 0.000 description 1
- 238000010953 Ames test Methods 0.000 description 1
- 231100000039 Ames test Toxicity 0.000 description 1
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 1
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 1
- GMFAGHNRXPSSJS-SRVKXCTJSA-N Arg-Leu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GMFAGHNRXPSSJS-SRVKXCTJSA-N 0.000 description 1
- MNBHKGYCLBUIBC-UFYCRDLUSA-N Arg-Phe-Phe Chemical compound C([C@H](NC(=O)[C@H](CCCNC(N)=N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MNBHKGYCLBUIBC-UFYCRDLUSA-N 0.000 description 1
- RYQSYXFGFOTJDJ-RHYQMDGZSA-N Arg-Thr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RYQSYXFGFOTJDJ-RHYQMDGZSA-N 0.000 description 1
- FMYQECOAIFGQGU-CYDGBPFRSA-N Arg-Val-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMYQECOAIFGQGU-CYDGBPFRSA-N 0.000 description 1
- CPTXATAOUQJQRO-GUBZILKMSA-N Arg-Val-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O CPTXATAOUQJQRO-GUBZILKMSA-N 0.000 description 1
- XXAOXVBAWLMTDR-ZLUOBGJFSA-N Asn-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N XXAOXVBAWLMTDR-ZLUOBGJFSA-N 0.000 description 1
- PPMTUXJSQDNUDE-CIUDSAMLSA-N Asn-Glu-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PPMTUXJSQDNUDE-CIUDSAMLSA-N 0.000 description 1
- JWQWPRCDYWNVNM-ACZMJKKPSA-N Asn-Ser-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N JWQWPRCDYWNVNM-ACZMJKKPSA-N 0.000 description 1
- NJIKKGUVGUBICV-ZLUOBGJFSA-N Asp-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O NJIKKGUVGUBICV-ZLUOBGJFSA-N 0.000 description 1
- ZVTDYGWRRPMFCL-WFBYXXMGSA-N Asp-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N ZVTDYGWRRPMFCL-WFBYXXMGSA-N 0.000 description 1
- HSWYMWGDMPLTTH-FXQIFTODSA-N Asp-Glu-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HSWYMWGDMPLTTH-FXQIFTODSA-N 0.000 description 1
- XDGBFDYXZCMYEX-NUMRIWBASA-N Asp-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)O XDGBFDYXZCMYEX-NUMRIWBASA-N 0.000 description 1
- QHHVSXGWLYEAGX-GUBZILKMSA-N Asp-His-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QHHVSXGWLYEAGX-GUBZILKMSA-N 0.000 description 1
- YRBGRUOSJROZEI-NHCYSSNCSA-N Asp-His-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O YRBGRUOSJROZEI-NHCYSSNCSA-N 0.000 description 1
- FAUPLTGRUBTXNU-FXQIFTODSA-N Asp-Pro-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O FAUPLTGRUBTXNU-FXQIFTODSA-N 0.000 description 1
- XMKXONRMGJXCJV-LAEOZQHASA-N Asp-Val-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XMKXONRMGJXCJV-LAEOZQHASA-N 0.000 description 1
- XWKPSMRPIKKDDU-RCOVLWMOSA-N Asp-Val-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O XWKPSMRPIKKDDU-RCOVLWMOSA-N 0.000 description 1
- GIKOVDMXBAFXDF-NHCYSSNCSA-N Asp-Val-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GIKOVDMXBAFXDF-NHCYSSNCSA-N 0.000 description 1
- 108010072454 CTGCAG-specific type II deoxyribonucleases Proteins 0.000 description 1
- LHJDLVVQRJIURS-SRVKXCTJSA-N Cys-Phe-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N LHJDLVVQRJIURS-SRVKXCTJSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- PKVWNYGXMNWJSI-CIUDSAMLSA-N Gln-Gln-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKVWNYGXMNWJSI-CIUDSAMLSA-N 0.000 description 1
- RBWKVOSARCFSQQ-FXQIFTODSA-N Gln-Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O RBWKVOSARCFSQQ-FXQIFTODSA-N 0.000 description 1
- XFAUJGNLHIGXET-AVGNSLFASA-N Gln-Leu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XFAUJGNLHIGXET-AVGNSLFASA-N 0.000 description 1
- SFAFZYYMAWOCIC-KKUMJFAQSA-N Gln-Phe-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SFAFZYYMAWOCIC-KKUMJFAQSA-N 0.000 description 1
- KVQOVQVGVKDZNW-GUBZILKMSA-N Gln-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N KVQOVQVGVKDZNW-GUBZILKMSA-N 0.000 description 1
- WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 1
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- AVZHGSCDKIQZPQ-CIUDSAMLSA-N Glu-Arg-Ala Chemical compound C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AVZHGSCDKIQZPQ-CIUDSAMLSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- KRGZZKWSBGPLKL-IUCAKERBSA-N Glu-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N KRGZZKWSBGPLKL-IUCAKERBSA-N 0.000 description 1
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 1
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 1
- OCJRHJZKGGSPRW-IUCAKERBSA-N Glu-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O OCJRHJZKGGSPRW-IUCAKERBSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- NTHIHAUEXVTXQG-KKUMJFAQSA-N Glu-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O NTHIHAUEXVTXQG-KKUMJFAQSA-N 0.000 description 1
- QITBQGJOXQYMOA-ZETCQYMHSA-N Gly-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QITBQGJOXQYMOA-ZETCQYMHSA-N 0.000 description 1
- FQKKPCWTZZEDIC-XPUUQOCRSA-N Gly-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 FQKKPCWTZZEDIC-XPUUQOCRSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- TVUWMSBGMVAHSJ-KBPBESRZSA-N Gly-Leu-Phe Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TVUWMSBGMVAHSJ-KBPBESRZSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- MTBIKIMYHUWBRX-QWRGUYRKSA-N Gly-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN MTBIKIMYHUWBRX-QWRGUYRKSA-N 0.000 description 1
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 1
- YDIDLLVFCYSXNY-RCOVLWMOSA-N Gly-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN YDIDLLVFCYSXNY-RCOVLWMOSA-N 0.000 description 1
- NGRPGJGKJMUGDM-XVKPBYJWSA-N Gly-Val-Gln Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NGRPGJGKJMUGDM-XVKPBYJWSA-N 0.000 description 1
- IDQKGZWUPVOGPZ-GUBZILKMSA-N His-Cys-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N IDQKGZWUPVOGPZ-GUBZILKMSA-N 0.000 description 1
- CTGZVVQVIBSOBB-AVGNSLFASA-N His-His-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O CTGZVVQVIBSOBB-AVGNSLFASA-N 0.000 description 1
- BZKDJRSZWLPJNI-SRVKXCTJSA-N His-His-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O BZKDJRSZWLPJNI-SRVKXCTJSA-N 0.000 description 1
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 1
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 1
- JSQIXEHORHLQEE-MEYUZBJRSA-N His-Phe-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JSQIXEHORHLQEE-MEYUZBJRSA-N 0.000 description 1
- PYNPBMCLAKTHJL-SRVKXCTJSA-N His-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O PYNPBMCLAKTHJL-SRVKXCTJSA-N 0.000 description 1
- UXZMINKIEWBEQU-SZMVWBNQSA-N His-Trp-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N UXZMINKIEWBEQU-SZMVWBNQSA-N 0.000 description 1
- PBJOQLUVSGXRSW-YTQUADARSA-N His-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)N)C(=O)O PBJOQLUVSGXRSW-YTQUADARSA-N 0.000 description 1
- KUHFPGIVBOCRMV-MNXVOIDGSA-N Ile-Gln-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N KUHFPGIVBOCRMV-MNXVOIDGSA-N 0.000 description 1
- CIJLNXXMDUOFPH-HJWJTTGWSA-N Ile-Pro-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CIJLNXXMDUOFPH-HJWJTTGWSA-N 0.000 description 1
- YJRSIJZUIUANHO-NAKRPEOUSA-N Ile-Val-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)O)N YJRSIJZUIUANHO-NAKRPEOUSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 1
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 1
- KXCMQWMNYQOAKA-SRVKXCTJSA-N Leu-Met-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KXCMQWMNYQOAKA-SRVKXCTJSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- BMVFXOQHDQZAQU-DCAQKATOSA-N Leu-Pro-Asp Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N BMVFXOQHDQZAQU-DCAQKATOSA-N 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
- NDORZBUHCOJQDO-GVXVVHGQSA-N Lys-Gln-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O NDORZBUHCOJQDO-GVXVVHGQSA-N 0.000 description 1
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 1
- QOJDBRUCOXQSSK-AJNGGQMLSA-N Lys-Ile-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O QOJDBRUCOXQSSK-AJNGGQMLSA-N 0.000 description 1
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 1
- VSTNAUBHKQPVJX-IHRRRGAJSA-N Lys-Met-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O VSTNAUBHKQPVJX-IHRRRGAJSA-N 0.000 description 1
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 1
- JUXONJROIXKHEV-GUBZILKMSA-N Met-Cys-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCNC(N)=N JUXONJROIXKHEV-GUBZILKMSA-N 0.000 description 1
- WWWGMQHQSAUXBU-BQBZGAKWSA-N Met-Gly-Asn Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O WWWGMQHQSAUXBU-BQBZGAKWSA-N 0.000 description 1
- GWADARYJIJDYRC-XGEHTFHBSA-N Met-Thr-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GWADARYJIJDYRC-XGEHTFHBSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- MQWISMJKHOUEMW-ULQDDVLXSA-N Phe-Arg-His Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 MQWISMJKHOUEMW-ULQDDVLXSA-N 0.000 description 1
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 1
- SWZKMTDPQXLQRD-XVSYOHENSA-N Phe-Asp-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWZKMTDPQXLQRD-XVSYOHENSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 1
- METZZBCMDXHFMK-BZSNNMDCSA-N Phe-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N METZZBCMDXHFMK-BZSNNMDCSA-N 0.000 description 1
- WDOCBGZHAQQIBL-IHPCNDPISA-N Phe-Trp-Ser Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CO)C(O)=O)C1=CC=CC=C1 WDOCBGZHAQQIBL-IHPCNDPISA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- XUSDDSLCRPUKLP-QXEWZRGKSA-N Pro-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 XUSDDSLCRPUKLP-QXEWZRGKSA-N 0.000 description 1
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 1
- HFNPOYOKIPGAEI-SRVKXCTJSA-N Pro-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 HFNPOYOKIPGAEI-SRVKXCTJSA-N 0.000 description 1
- JLMZKEQFMVORMA-SRVKXCTJSA-N Pro-Pro-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 JLMZKEQFMVORMA-SRVKXCTJSA-N 0.000 description 1
- CXGLFEOYCJFKPR-RCWTZXSCSA-N Pro-Thr-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O CXGLFEOYCJFKPR-RCWTZXSCSA-N 0.000 description 1
- RJTUIDFUUHPJMP-FHWLQOOXSA-N Pro-Trp-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC4=CN=CN4)C(=O)O RJTUIDFUUHPJMP-FHWLQOOXSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- MLSQXWSRHURDMF-GARJFASQSA-N Ser-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CO)N)C(=O)O MLSQXWSRHURDMF-GARJFASQSA-N 0.000 description 1
- JWOBLHJRDADHLN-KKUMJFAQSA-N Ser-Leu-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JWOBLHJRDADHLN-KKUMJFAQSA-N 0.000 description 1
- AXOHAHIUJHCLQR-IHRRRGAJSA-N Ser-Met-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CO)N AXOHAHIUJHCLQR-IHRRRGAJSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 1
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 1
- JBHMLZSKIXMVFS-XVSYOHENSA-N Thr-Asn-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JBHMLZSKIXMVFS-XVSYOHENSA-N 0.000 description 1
- BNGDYRRHRGOPHX-IFFSRLJSSA-N Thr-Glu-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O BNGDYRRHRGOPHX-IFFSRLJSSA-N 0.000 description 1
- NQVDGKYAUHTCME-QTKMDUPCSA-N Thr-His-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O NQVDGKYAUHTCME-QTKMDUPCSA-N 0.000 description 1
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 1
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 1
- GJOBRAHDRIDAPT-NGTWOADLSA-N Thr-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H]([C@@H](C)O)N GJOBRAHDRIDAPT-NGTWOADLSA-N 0.000 description 1
- YYXIWHBHTARPOG-HJXMPXNTSA-N Trp-Ile-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N YYXIWHBHTARPOG-HJXMPXNTSA-N 0.000 description 1
- OFTGYORHQMSPAI-PJODQICGSA-N Trp-Met-Ala Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O OFTGYORHQMSPAI-PJODQICGSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- BVDHHLMIZFCAAU-BZSNNMDCSA-N Tyr-Cys-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BVDHHLMIZFCAAU-BZSNNMDCSA-N 0.000 description 1
- YYZPVPJCOGGQPC-JYJNAYRXSA-N Tyr-His-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYZPVPJCOGGQPC-JYJNAYRXSA-N 0.000 description 1
- SYFHQHYTNCQCCN-MELADBBJSA-N Tyr-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O SYFHQHYTNCQCCN-MELADBBJSA-N 0.000 description 1
- LDKDSFQSEUOCOO-RPTUDFQQSA-N Tyr-Thr-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LDKDSFQSEUOCOO-RPTUDFQQSA-N 0.000 description 1
- WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 1
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 1
- VMRFIKXKOFNMHW-GUBZILKMSA-N Val-Arg-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N VMRFIKXKOFNMHW-GUBZILKMSA-N 0.000 description 1
- DBOXBUDEAJVKRE-LSJOCFKGSA-N Val-Asn-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N DBOXBUDEAJVKRE-LSJOCFKGSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 1
- MLADEWAIYAPAAU-IHRRRGAJSA-N Val-Lys-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MLADEWAIYAPAAU-IHRRRGAJSA-N 0.000 description 1
- YQMILNREHKTFBS-IHRRRGAJSA-N Val-Phe-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N YQMILNREHKTFBS-IHRRRGAJSA-N 0.000 description 1
- JSOXWWFKRJKTMT-WOPDTQHZSA-N Val-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N JSOXWWFKRJKTMT-WOPDTQHZSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000010227 enterocolitis Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 231100000722 genetic damage Toxicity 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 108010015666 tryptophyl-leucyl-glutamic acid Proteins 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a high-throughput screening method for genotoxic substances, and relates to the technical field of genotoxicity high-throughput screening. The method comprises the steps of inserting a coding nitroreductase gene, a coding O-acetyltransferase gene, a DNA damage detection response element and a phage lysis gene into an escherichia coli expression vector to obtain a recombinant vector; transferring the recombinant vector into escherichia coli to obtain recombinant escherichia coli; the recombinant Escherichia coli is applied to high-throughput detection of genotoxic substances. The operation object of the screening method is escherichia coli, no pathogenic risk exists, and the operation is simple and easy; the test period is short, and the completion can be detected within 2 h; the detection sensitivity is high; therefore, the method has the advantages of convenient operation, short time consumption, high detection efficiency, no need of adding additional chemical reagents, no interference of pigments, low cost, time and labor saving, and easy realization of high-throughput sample detection.
Description
Technical Field
The invention relates to the technical field of high-throughput screening of genotoxicity, in particular to a high-throughput screening method of genotoxicity substances.
Background
In recent years it has been found that in the production of pharmaceuticals, pesticides and dyes, uncontrolled release of certain amounts of genotoxic compounds such as Nitro Polycyclic Aromatic Hydrocarbons (NPAH), nitro containing pesticides, phenols etc. into the air, soil and water poses potential risks for the ecological environment and human health. Some of the nitro-containing compounds undergo metabolism in the human body by various enzyme systems to activate their biological activities and cause irreversible genetic damage to human cells. Therefore, there is also an increasing need for the detection of such stress factors.
Currently, the main methods available for screening the genetic toxicity of nitro-containing compounds include the Salmonella typhimurium back mutation test (also known as Ames test) and the SOS/umu test. However, salmonella typhimurium is a pathogenic bacterium which is harmful to human and livestock, and can cause diseases such as acute gastroenteritis, enterocolitis, typhoid fever, paratyphoid fever, septicemia and the like, so that the experimental safety is poor. The detection method generally has the factors which are not beneficial to popularization, such as complicated operation, long detection time, incapability of realizing high flux, need of strict sterile operation and the like. And due to the reasons of patent protection and the like, individual detection methods are not favorable for domestic popularization, and the wide application of the detection methods is limited.
Disclosure of Invention
In order to overcome the defects and shortcomings of the prior art, the invention aims to provide a high-throughput screening method for genotoxic substances. The screening method is convenient to operate, short in time consumption, free of additional chemical reagent addition, free of pigment interference and easy to realize high-throughput sample detection.
The purpose of the invention is realized by the following technical scheme:
the invention provides a high-throughput screening method for genotoxic substances, which comprises the following steps:
the method comprises the following steps: inserting a coding nitroreductase gene, a coding O-acetyltransferase gene, a DNA damage detection response element and a phage lysis gene into an escherichia coli expression vector to obtain a recombinant vector; transferring the recombinant vector into escherichia coli to obtain recombinant escherichia coli;
step two: preparing an escherichia coli detection solution by using the recombinant escherichia coli, incubating the escherichia coli detection solution and a sample to be detected in a microporous plate, and cracking escherichia coli cells; simultaneously adding a pure solvent with the same volume of escherichia coli detection solution as a control; calculating the survival rate of the thalli by absorbance to realize high-throughput detection;
or,
step three: calculating the relative survival rate through the survival rate of escherichia coli and the survival rate of recombinant escherichia coli, and realizing high-throughput detection;
relative survival (%) ═ B/a 100%; wherein, the survival rate of A-escherichia coli and the survival rate of B-recombinant escherichia coli.
The recombinant vector has the structural elements shown in figure 1.
In the recombinant vector, a coding nitroreductase gene, a coding O-acetyltransferase gene, a DNA damage detection response element and a phage lysis gene are sequentially arranged from 5 'to 3'.
The encoding nitroreductase gene can be any encoding nitroreductase gene, preferably an encoding nitroreductase gene nfSB of SGSC1412 salmonella typhimurium, and the gene sequence is SEQ ID NO. 1; the amino acid sequence of the nitroreductase is SEQ ID NO. 5.
The coding O-acetyltransferase gene can be any coding O-acetyltransferase gene, preferably a coding O-acetyltransferase gene nhoA of SGSC1412 salmonella typhimurium, and the gene sequence is SEQ ID NO. 2; the amino acid sequence of the O-acetyltransferase is SEQ ID NO. 6.
Preferably, the nucleotide sequence of the DNA damage detection response element is SEQ ID NO. 3.
The phage lysis gene can be any phage lysis gene, preferably the lysis gene SRrz of lambda phage, and the gene sequence is SEQ ID NO. 4.
In the second step, the microplate can be selected from 96-well plates, 48-well plates, 24-well plates and the like.
In the second step, the incubation time is preferably 15-60 min; further 20 min.
In the second step, the absorbance is at 600nmYield, which can be recorded as OD600。
In the second step, the method specifically comprises the following steps:
(1) preparing an escherichia coli detection solution by using the recombinant escherichia coli;
(2) mixing a sample to be detected and the escherichia coli detection solution in a microporous plate, and adding the escherichia coli detection solution with the same volume of pure solvent as a control; continuously culturing the two groups of samples for 15-60 min;
(3) respectively measuring OD of the Escherichia coli detection solution mixed with the sample to be measured and the Escherichia coli detection solution of the control group600;
(4) And (5) calculating the survival rate, and calculating the genotoxicity degree of the sample to be detected according to the survival rate standard curve.
The preparation steps of the escherichia coli detection solution are as follows:
1) culturing the recombinant escherichia coli stock with an LB solid culture medium to recover and activate the recombinant escherichia coli stock;
2) inoculating the obtained activated escherichia coli single colony into an LB liquid culture medium for shake culture to the late stage of logarithmic phase to obtain saturated bacterial liquid;
3) inoculating the obtained saturated bacterial liquid into a fresh LB liquid culture medium in a volume ratio of 1: 100, and culturing until bacterial liquid OD6000.1-0.4, adding IPTG to a final concentration of 0.01-0.2 mM, and performing induction culture to obtain an escherichia coli detection solution.
In the step 3), the induction culture time is preferably 1-1.5 h.
The Escherichia coli expression vector can be any Escherichia coli vector, such as pBluescript, pUC18, pUC19, pET series vectors (such as pET30a (+)) and the like. pUC18 is used as starting vector, and the constructed Escherichia coli cracking vector is pUSTBA.
The Escherichia coli is E.coli BL21(DE3), E.coli DH5a, E.coli XL1-blue or E.coli HB 101.
The genetic toxic substance can be a nitro-containing compound, specifically at least one of 1-nitronaphthalene (1-NN), 2-nitrofluorene (2-NF), 5-nitroacenaphthene (5-NA) and the like;
the standard curve of the thallus survival rate is as follows:
1-NN,Y=54.37+(97.81-54.37)/{1+10(17.74-log X)×(-0.1095)},R2=0.99(2≤X≤170);
2-NF,Y=66.13+(100.2-66.13)/{1+10(1.117-log X)×(-3.676)},R2=0.99(0.5≤X≤2.5);
5-NA,Y=65.39+(100.8-65.39)/{1+10(2.586-log X)×(-0.5784)},R2=0.99(0.125≤X≤15)。
wherein X represents the concentration (. mu. mol/L) of a genotoxic substance, Y represents the cell survival rate (%), and R2Representing curve fit correlation coefficients.
The genetic toxic substance can also be a common pesticide, and is at least one of organic phosphate, aniline (except iprodione), amide, formate, tert-butyl sulfide, phenol, microorganism pesticides, and the like; the method specifically comprises the following steps: at least one of trichlorphon, dichlorvos-cypermethrin, glufosinate-ammonium, imidacloprid, cyromazine, pendimethalin, biphenyl-thiamethoxam, pythium-thiram, carfentrazone-zineb, carbendazim, emamectin benzoate, pyridaben, abamectin-diafenthiuron, compound sodium nitrophenolate and abamectin.
Recombinant Escherichia coli containing the recombinant vector also belongs to the protection scope of the invention.
Compared with the prior art, the invention has the following advantages and effects:
(1) the operation object is escherichia coli, no pathogenic risk exists, and the operation is simple and easy.
(2) The test period is short, and the test can be completed within 2 h.
(3) The detection process does not need to add additional reagents (such as enzyme substrates and the like), and the cost is low.
(4) The detection sensitivity is high, and the sensitivity concentration ranges of the detection to 1-NN, 2-NF and 5-NA are respectively 2-170, 0.5-2.5 and 0.125-15 mu mol/L.
(5) High-flux screening can be realized, the detection efficiency is high, and time and labor are saved.
Drawings
FIG. 1 is a schematic diagram of the construction of the genotoxicity test vector in example 1.
FIG. 2 is a graph showing the cleavage response of the recombinant E.coli (E.coli BL21(DE3)/pUSTBA) in example 2 to nitro-containing compounds having genetic toxicity to 1-NN, 2-NF, and 5-NA.
FIG. 3 is a schematic diagram of the experimental protocol of the conventional pesticide in 96-well plate in example 3.
Detailed Description
The present invention will be described in further detail with reference to examples and drawings, but the present invention is not limited thereto.
The test methods in the following examples, in which specific experimental conditions are not specified, are generally performed according to conventional experimental conditions or according to the experimental conditions recommended by the manufacturer. The materials, reagents and the like used are, unless otherwise specified, reagents and materials obtained from commercial sources.
Example 1 genetic toxicity test vector construction
And constructing a genetic toxicity detection vector pUST by taking pUC18 as a starting vector. The specific construction method comprises the following steps:
1. synthetic DNA Damage detection response element Pumu(SEQ ID NO.3) and the T7 terminator sequence, at PumuXbaI site is added at the upstream, and SpeI enzyme cutting site is added at the downstream; an EcoRI site was added upstream of the T7 terminator and a SmaI cleavage site was added downstream, and the sequence was designated as T7T.
2. The SRrz gene (SEQ ID NO.4) was amplified using lambda phage genomic DNA as a template. SpeI and EcoRI restriction sites are added to the upstream and downstream of the SRrz gene.
3. Adopting a biological building block (Biofricks) method, adopting an enzyme digestion and connection method to make each element according to a promoter PumuThe terminator sequence of the split gene SRrz-T7 is ligated and inserted into the pUC18 vector to obtain the genotoxic response vector pUST.
4. Synthesizing a T7 promoter and a T7 terminator sequence, adding a KpnI restriction site at the upstream of a T7 promoter, and adding a BamHI restriction site at the downstream, wherein the KpnI restriction site is marked as T7-1; SmaI restriction enzyme cutting site is added at the upstream of another T7 promoter, and PstI restriction enzyme cutting site is added at the downstream, which is marked as T7-2; an XhoI cleavage site was added upstream of the T7 terminator and an NdeI cleavage site was added downstream, as indicated by T7T-1.
5. SGSC1412 Salmonella typhimurium genome DNA is used as a template to amplify the nfSB gene (SEQ ID NO.1) and the nhoA gene (SEQ ID NO.2) respectively. A BamHI cleavage site was added upstream of the nfSB gene, a SmaI cleavage site was added downstream, a PstI cleavage site was added upstream of the nhoA gene, and an XhoI cleavage site was added downstream.
6. And (3) connecting the elements according to the sequence of a promoter-nfSB-promoter-nhoA-terminator by adopting a biological building block (Biofricks) method and adopting an enzyme digestion and connection method, and inserting the elements into a pUST vector to obtain a genetic toxicity detection vector pUSTBA. A schematic of the vector construction is shown in FIG. 1.
7. Transferring the vector pUSTBA or pUST into E.coli BL21(DE3) competent cells to obtain recombinant Escherichia coli E.coli BL21(DE3)/pUSTBA or E.coli BL21(DE3)/pUST for detecting genotoxic substances.
EXAMPLE 2 Nitro Compound genotoxicity test
Calculation of survival
20min after the Escherichia coli detection liquid contacts the sample to be detected, respectively determining the light absorption value (OD) of each test bacterial liquid at 600nm600)。
Survival rate (%). B/A100%
Wherein, A-bacterial liquid OD added with dimethyl sulfoxide600
B bacterial liquid OD added with sample to be detected600。
1. Resuscitation and activation of recombinant escherichia coli
Recombinant E.coli BL21(DE3)/pUSTBA was taken out from a-80 ℃ refrigerator, streaked on LB plate medium, and cultured at 37 ℃ for 14 hours. And (3) selecting a single colony, inoculating the single colony into an LB culture solution, and culturing for 12-16 h at 37 ℃ and 250rpm to obtain a saturated bacterial solution.
2. Preparation of Escherichia coli detection solution
Inoculating the revived and activated saturated bacterial liquid to a fresh LB culture medium according to the volume ratio of 1: 100, adding 190 mu L of the saturated bacterial liquid into a 96-hole culture plate, and culturing the saturated bacterial liquid to OD under the conditions of 35-38 ℃ and 600-1000 rpm600Adding IPTG to a final concentration of 0.1-0.401-0.2 mM, and inducing culture for about 1-1.5 h to obtain Escherichia coli detection solution.
3. Contact with the sample to be tested
Preparing a solution with a certain concentration gradient and containing a nitro compound (1-NN, 2-NF or 5-NA) as a sample to be detected; wherein the concentration gradient of 1-NN in the solution containing 1-NN is 2, 6, 20, 58 and 170 mu mol/L; the concentration gradient of 2-NF in the solution containing 2-NF is 0.5, 0.75, 1, 1.5, 2 and 2.5 mu mol/L; the 5-NA concentration gradient in the 5-NA-containing solution was 0.125, 0.63, 1.25, 3.5, 15. mu. mol/L.
And adding 10 mu L of sample to be detected into the 96-well plate, continuously culturing for 20 minutes at 35-38 ℃ and 800rpm, and setting 3 parallel groups. The addition of the same volume of pure solvent (dimethyl sulfoxide), and the same volume of sample at the same concentration to the recombinant e.coli BL21(DE 3)/psust strain and the wild-type e.coli BL21(DE3) strain were set as negative controls at the same time.
4. Experimental results show that under the saturation concentration conditions (170 mu mol/L1-NN, 2.5 mu mol/L2-NF and 15 mu mol/L5-NA), a recombinant E.coli BL21(DE3)/pUST strain which is lack of a nitroreductase gene (nfSB) and an O-acetyltransferase gene (nhoA) in a genotoxic response vector pUST and a wild E.coli BL21(DE3) strain which does not contain a genotoxic response vector grow normally, and the thalli are not cracked. Coli BL21(DE 3)/reustba strain, however, exhibited different degrees of lysis. In this example, the detection result is shown in fig. 2, and the standard curve of each nitro compound detection corresponds to:
1-NN,Y=54.37+(97.81-54.37)/{1+10(17.74-log X)×(-0.1095)},R2=0.99(2≤X≤170);
2-NF,Y=66.13+(100.2-66.13)/{1+10(1.117-log X)×(-3.676)},R2=0.99(0.5≤X≤2.5);
5-NA,Y=65.39+(100.8-65.39)/{1+10(2.586-log X)×(-0.5784)},R2=0.99(0.125≤X≤15)。
wherein X represents the concentration (. mu. mol/L) of a genotoxic substance, Y represents the cell survival rate (%), and R2Representing curve fit correlation coefficients.
The results show that the sample concentration and the thallus survival rate have dose correlation within the detection concentration range. Therefore, the strain E.coli BL21(DE3)/pUSTBA can be used for detecting whether the sample containing the nitro compound has genetic toxicity or not.
Example 3 high throughput screening of genotoxicity of commonly used pesticides
In this example, the genetic toxicity screening is performed by using the conventional pesticide, and the survival rate of the thallus is used as a standard index. The corresponding degree of genotoxicity of the pesticide can be detected and reflected as the relative survival rate.
Relative survival (%) ═ B/A100%
Wherein, the survival rate of A-wild type E.coli BL21(DE3) strain
Coli BL21(DE3)/pUSTBA survival rate
1. An E.coli BL21(DE3)/pUSTBA test medium, an E.coli BL21(DE3)/pUST test medium, and a wild-type E.coli BL21(DE3) test medium were prepared in accordance with the procedure 1-2 of example 2.
2. The pesticides to be tested are respectively dissolved in dimethyl sulfoxide according to a certain proportion, and the dilution proportion is shown in table 1. Referring to example 2, in a 96-well plate, a pesticide to be detected was mixed with an escherichia coli detection solution, and an escherichia coli detection solution of the same volume of a pure solvent (dimethyl sulfoxide) was added as a control; both samples were incubated for 20 min. The pesticides are all purchased from a pesticide store in Dongguan.
3. The experimental protocol is shown in figure 3.
4. Respectively measuring OD of the Escherichia coli detection solution mixed with the pesticide to be measured and the Escherichia coli detection solution of the control group600。
5. The relative survival rates were calculated and the results are shown in table 1.
TABLE 1 relative survival rates of conventional pesticides
The results in Table 1 show that the screened pesticide containing the nitro compound has certain genetic toxicity, and the relative survival rates of E.coli BL21(DE3)/pUSTBA induced by the pesticide of the cinnabar, the pendimethalin, the biphenyl-thiamethoxam and the compound sodium nitrophenolate are 53-89%, and are lower than the relative survival rates of E.coli BL21(DE3)/pUST without the codes of nitroreductase (nfSB) and O-acetyltransferase (nhoA). The pesticides of organic phosphates, anilines, amides (except iprodione), formate, tert-butyl sulfenyl, phenols and microorganisms all contain certain genetic toxicity, wherein the relative survival rate of trichlorfon, glufosinate-ammonium, pythium-thiram, pyridaben and abamectin induced E.coli BL21(DE3)/pUSTBA is only below 70%, and the relative survival rate of E.coli BL21(DE3)/pUST is above 90%.
The detection result shows that the method for screening the genetic toxicity containing the nitro compound detects the substance to be detected within the response concentration range, finally expresses the genetic toxicity content of the sample to be detected by the relative cell survival rate, and can realize high-throughput screening in a 96-well plate. The method has the advantages of no risk of disease, simple operation, high detection sensitivity, time and labor saving and easy popularization.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Sequence listing
<110> university of southern China's science
<120> a high throughput screening method for genotoxic substances
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 654
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> sequence encoding nitroreductase Gene nfSB
<400> 1
atggatatcg tttctgtcgc cttacagcgc tactccacta aggcgttcga tcccagcaaa 60
aaactgaccg ccgaagaagc ggataaaata aaaacactac tacagtacag cccctccagc 120
accaattccc agccgtggca ctttattgtc gccagtacgg aagaaggcaa agcgcgcgta 180
gcaaaatccg ctgccggaaa ctacacgttc aacgaacgca aaatgctgga cgcctcccat 240
gtggtggtct tctgcgccaa aaccgcaatg gatgacgcat ggcttgagcg cgtcgtcgat 300
caggaagatg ctgatggccg tttcgctacg ccggaagcta aagcggcaaa tgataaaggt 360
cgccgctttt tcgccgatat gcaccgcgtc tcgctgaaag atgaccacca gtggatggcg 420
aagcaggttt atctgaacgt cggcaacttt ctgctgggcg tcgccgcgat gggtctcgac 480
gccgtcccca ttgaaggttt cgacgccgag gtgctcgacg ctgaatttgg tctgaaagaa 540
aaaggctata ccagtctggt cgtggtgccg gtcggccatc atagcgtcga ggatttcaac 600
gccgggctgc cgaaatcacg tctgccgctt gaaaccacac tgacggaagt ttaa 654
<210> 2
<211> 846
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> sequence encoding O-acetyltransferase Gene nhoA
<400> 2
atgacctctt ttttacatgc ttattttacg cgattacatt gtcagccgtt gggggttcct 60
acggttgaag cgctcagaac gcttcactta gcgcacaact gcgcgattcc ttttgaaaat 120
ctggatgtgc tactgcctcg tgaaatacag ctcgatgaga cggcattaga ggagaaactg 180
ctttatgccc gacgcggtgg atactgtttt gaactgaatg gcctgtttga acgcgcgtta 240
cgcgacatcg gttttaacgt ccgaagctta ttggggcggg tcattctgtc tcatcccgcc 300
agtttaccgc cgcgcacgca ccgtttgctg ctggttgatg ttgaggatga gcagtggatc 360
gcggacgtgg ggtttggcgg ccaaacgcta accgcaccgc ttcgtctgca ggctgaaatt 420
gcccagcaaa cgccgcatgg cgaataccgc ctgatgcagg agggaagcac atggatttta 480
caattccgcc accatgagca ctggcagtcg atgtactgtt ttgatctggg ggtgcagcag 540
cagagcgatc atgtgatggg caatttctgg tcggctcact ggccgcaatc ccattttcgt 600
catcatttgt tgatgtgccg ccatttgcct gatggcggca agctgacatt aacgaatttc 660
cacttcacgc gttaccacca gggacatgcc gttgaacagg tcaatgtacc ggatgtaccg 720
tcgttgtatc agttacttca gcagcagttt ggtctcggcg taaatgatgt aaagcacggt 780
tttaccgagg cggagctggc cgcggtaatg gctgcatttg atacccatcc agaggcggga 840
aaataa 846
<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> nucleotide sequence of response element for DNA damage detection
<400> 3
tactgtatat aaaaacagta 20
<210> 4
<211> 1549
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> sequence of cleavage Gene SRrz
<400> 4
gccactgtct gtcctgaatt cattagtaat agttacgctg cggcctttta cacatgacct 60
tcgtgaaagc gggtggcagg aggtcgcgct aacaacctcc tgccgttttg cccgtgcata 120
tcggtcacga acaaatctga ttactaaaca cagtagcctg gatttgttct atcagtaatc 180
gaccttattc ctaattaaat agagcaaatc cccttattgg gggtaagaca tgaagatgcc 240
agaaaaacat gacctgttgg ccgccattct cgcggcaaag gaacaaggca tcggggcaat 300
ccttgcgttt gcaatggcgt accttcgcgg cagatataat ggcggtgcgt ttacaaaaac 360
agtaatcgac gcaacgatgt gcgccattat cgcctggttc attcgtgacc ttctcgactt 420
cgccggacta agtagcaatc tcgcttatat aacgagcgtg tttatcggct acatcggtac 480
tgactcgatt ggttcgctta tcaaacgctt cgctgctaaa aaagccggag tagaagatgg 540
tagaaatcaa taatcaacgt aaggcgttcc tcgatatgct ggcgtggtcg gagggaactg 600
ataacggacg tcagaaaacc agaaatcatg gttatgacgt cattgtaggc ggagagctat 660
ttactgatta ctccgatcac cctcgcaaac ttgtcacgct aaacccaaaa ctcaaatcaa 720
caggcgccgg acgctaccag cttctttccc gttggtggga tgcctaccgc aagcagcttg 780
gcctgaaaga cttctctccg aaaagtcagg acgctgtggc attgcagcag attaaggagc 840
gtggcgcttt acctatgatt gatcgtggtg atatccgtca ggcaatcgac cgttgcagca 900
atatctgggc ttcactgccg ggcgctggtt atggtcagtt cgagcataag gctgacagcc 960
tgattgcaaa attcaaagaa gcgggcggaa cggtcagaga gattgatgta tgagcagagt 1020
caccgcgatt atctccgctc tggttatctg catcatcgtc tgcctgtcat gggctgttaa 1080
tcattaccgt gataacgcca ttacctacaa agcccagcgc gacaaaaatg ccagagaact 1140
gaagctggcg aacgcggcaa ttactgacat gcagatgcgt cagcgtgatg ttgctgcgct 1200
cgatgcaaaa tacacgaagg agttagctga tgctaaagct gaaaatgatg ctctgcgtga 1260
tgatgttgcc gctggtcgtc gtcggttgca catcaaagca gtctgtcagt cagtgcgtga 1320
agccaccacc gcctccggcg tggataatgc agcctccccc cgactggcag acaccgctga 1380
acgggattat ttcaccctca gagagaggct gatcactatg caaaaacaac tggaaggaac 1440
ccagaagtat attaatgagc agtgcagata gagttgccca tatcgatggg caactcatgc 1500
aattattgtg agcaatacac acgcgcttcc agcggagtat aaatgccta 1549
<210> 5
<211> 217
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> amino acid sequence of nitroreductase
<400> 5
Met Asp Ile Val Ser Val Ala Leu Gln Arg Tyr Ser Thr Lys Ala Phe
1 5 10 15
Asp Pro Ser Lys Lys Leu Thr Ala Glu Glu Ala Asp Lys Ile Lys Thr
20 25 30
Leu Leu Gln Tyr Ser Pro Ser Ser Thr Asn Ser Gln Pro Trp His Phe
35 40 45
Ile Val Ala Ser Thr Glu Glu Gly Lys Ala Arg Val Ala Lys Ser Ala
50 55 60
Ala Gly Asn Tyr Thr Phe Asn Glu Arg Lys Met Leu Asp Ala Ser His
65 70 75 80
Val Val Val Phe Cys Ala Lys Thr Ala Met Asp Asp Ala Trp Leu Glu
85 90 95
Arg Val Val Asp Gln Glu Asp Ala Asp Gly Arg Phe Ala Thr Pro Glu
100 105 110
Ala Lys Ala Ala Asn Asp Lys Gly Arg Arg Phe Phe Ala Asp Met His
115 120 125
Arg Val Ser Leu Lys Asp Asp His Gln Trp Met Ala Lys Gln Val Tyr
130 135 140
Leu Asn Val Gly Asn Phe Leu Leu Gly Val Ala Ala Met Gly Leu Asp
145 150 155 160
Ala Val Pro Ile Glu Gly Phe Asp Ala Glu Val Leu Asp Ala Glu Phe
165 170 175
Gly Leu Lys Glu Lys Gly Tyr Thr Ser Leu Val Val Val Pro Val Gly
180 185 190
His His Ser Val Glu Asp Phe Asn Ala Gly Leu Pro Lys Ser Arg Leu
195 200 205
Pro Leu Glu Thr Thr Leu Thr Glu Val
210 215
<210> 6
<211> 281
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> amino acid sequence of O-acetyltransferase
<400> 6
Met Thr Ser Phe Leu His Ala Tyr Phe Thr Arg Leu His Cys Gln Pro
1 5 10 15
Leu Gly Val Pro Thr Val Glu Ala Leu Arg Thr Leu His Leu Ala His
20 25 30
Asn Cys Ala Ile Pro Phe Glu Asn Leu Asp Val Leu Leu Pro Arg Glu
35 40 45
Ile Gln Leu Asp Glu Thr Ala Leu Glu Glu Lys Leu Leu Tyr Ala Arg
50 55 60
Arg Gly Gly Tyr Cys Phe Glu Leu Asn Gly Leu Phe Glu Arg Ala Leu
65 70 75 80
Arg Asp Ile Gly Phe Asn Val Arg Ser Leu Leu Gly Arg Val Ile Leu
85 90 95
Ser His Pro Ala Ser Leu Pro Pro Arg Thr His Arg Leu Leu Leu Val
100 105 110
Asp Val Glu Asp Glu Gln Trp Ile Ala Asp Val Gly Phe Gly Gly Gln
115 120 125
Thr Leu Thr Ala Pro Leu Arg Leu Gln Ala Glu Ile Ala Gln Gln Thr
130 135 140
Pro His Gly Glu Tyr Arg Leu Met Gln Glu Gly Ser Thr Trp Ile Leu
145 150 155 160
Gln Phe Arg His His Glu His Trp Gln Ser Met Tyr Cys Phe Asp Leu
165 170 175
Gly Val Gln Gln Gln Ser Asp His Val Met Gly Asn Phe Trp Ser Ala
180 185 190
His Trp Pro Gln Ser His Phe Arg His His Leu Leu Met Cys Arg His
195 200 205
Leu Pro Asp Gly Gly Lys Leu Thr Leu Thr Asn Phe His Phe Thr Arg
210 215 220
Tyr His Gln Gly His Ala Val Glu Gln Val Asn Val Pro Asp Val Pro
225 230 235 240
Ser Leu Tyr Gln Leu Leu Gln Gln Gln Phe Gly Leu Gly Val Asn Asp
245 250 255
Val Lys His Gly Phe Thr Glu Ala Glu Leu Ala Ala Val Met Ala Ala
260 265 270
Phe Asp Thr His Pro Glu Ala Gly Lys
275 280
Claims (10)
1. A method for high throughput screening of genotoxic materials, comprising: the method comprises the following steps:
the method comprises the following steps: inserting a coding nitroreductase gene, a coding O-acetyltransferase gene, a DNA damage detection response element and a phage lysis gene into an escherichia coli expression vector to obtain a recombinant vector; transferring the recombinant vector into escherichia coli to obtain recombinant escherichia coli;
step two: preparing an escherichia coli detection solution by using the recombinant escherichia coli, incubating the escherichia coli detection solution and a sample to be detected in a microporous plate, and cracking escherichia coli cells; simultaneously adding a pure solvent with the same volume of escherichia coli detection solution as a control; calculating the survival rate of the thalli by absorbance to realize high-throughput detection;
or,
step three: calculating the relative survival rate through the survival rate of escherichia coli and the survival rate of recombinant escherichia coli, and realizing high-throughput detection;
relative survival (%) ═ B/a 100%; wherein, A is the survival rate of Escherichia coli, B is the survival rate of recombinant Escherichia coli;
the genetic toxic substance is a nitro-containing compound, and specifically is at least one of 1-nitronaphthalene, 2-nitrofluorene and 5-nitroacenaphthene;
or the genetic toxic substance is at least one of organic phosphate, anilines except iprodione, amides, formate, tert-butyl sulfenyl, phenols and microbial pesticides.
2. The high throughput screening method of claim 1, wherein:
in the recombinant vector, a coding nitroreductase gene, a coding O-acetyltransferase gene, a DNA damage detection response element and a phage lysis gene are sequentially arranged from 5 'to 3';
the amino acid sequence of the nitroreductase is SEQ ID NO. 5;
the amino acid sequence of the O-acetyltransferase is SEQ ID NO. 6.
3. High throughput screening method according to claim 1 or 2, characterized in that:
the sequence of the coding nitroreductase gene is SEQ ID NO. 1;
the gene sequence of the coding O-acetyltransferase is SEQ ID NO. 2;
the nucleotide sequence of the DNA damage detection response element is SEQ ID NO. 3;
the sequence of the phage lytic gene is SEQ ID NO. 4.
4. High throughput screening method according to claim 1 or 2, characterized in that:
in the second step, the micro-porous plate is selected from a 96-well plate, a 48-well plate or a 24-well plate;
in the second step, the incubation time is 15-60 min;
in the second step, the absorbance is the light absorption value at 600nm and is recorded as OD600。
5. High throughput screening method according to claim 4, characterized in that:
in the second step, the method specifically comprises the following steps:
(1) preparing an escherichia coli detection solution by using the recombinant escherichia coli;
(2) mixing a sample to be detected and the escherichia coli detection solution in a microporous plate, and adding the escherichia coli detection solution with the same volume of pure solvent as a control; continuously culturing the two groups of samples for 15-60 min;
(3) respectively measuring OD of the Escherichia coli detection solution mixed with the sample to be measured and the Escherichia coli detection solution of the control group600;
(4) And (5) calculating the survival rate, and calculating the genotoxicity degree of the sample to be detected according to the survival rate standard curve.
6. High throughput screening method according to claim 1 or 2 or 5, characterized in that:
the preparation steps of the escherichia coli detection solution are as follows:
1) culturing the recombinant escherichia coli stock with an LB solid culture medium to recover and activate the recombinant escherichia coli stock;
2) inoculating the obtained activated escherichia coli single colony into an LB liquid culture medium for shake culture to the late stage of logarithmic phase to obtain saturated bacterial liquid;
3) the obtained saturated bacterial liquid was mixed in a ratio of 1: inoculating into fresh LB liquid culture medium at a volume ratio of 100, and culturing to obtain bacterial liquid OD6000.1-0.4, adding IPTG to a final concentration of 0.01-0.2 mM, and performing induction culture to obtain an escherichia coli detection solution.
7. High throughput screening method according to claim 1 or 2, characterized in that:
the genotoxic substance is at least one of trichlorphon, dichlorvos-cypermethrin, glufosinate-ammonium, imidacloprid, cyromazine, pendimethalin, biphenyl-thiamethoxam, pythium-thiram, azol ether-zineb, carbendazim, emamectin benzoate, pyridaben, abamectin-diafenthiuron, compound sodium nitrophenolate and abamectin.
8. High throughput screening method according to claim 1 or 2, characterized in that:
the standard curve of the thallus survival rate is as follows:
1-nitronaphthalene, Y ═ 54.37+ (97.81-54.37)/{1+10(17.74-logX)×(-0.1095)},R2=0.99,2≤X≤170;
2-nitrofluorene, Y ═ 66.13+ (100.2-66.13)/{1+10(1.117-logX)×(-3.676)},R2=0.99,0.5≤X≤2.5;
5-nitroacenaphthylene, Y-65.39 + (100.8-65.39)/{1+10 +(2.586-logX)×(-0.5784)},R2=0.99,0.125≤X≤15;
Wherein X represents the concentration of genotoxic substances, mu mol/L; y represents the survival rate of the cells,% R2Representing curve fit correlation coefficients.
9. High throughput screening method according to claim 1 or 2, characterized in that:
the Escherichia coli expression vector is pBluescript, pUC18, pUC19 or pET series vector;
the Escherichia coli is E.coli BL21(DE3), E.coli DH5a, E.coli XL1-blue or E.coli HB 101.
10. The recombinant Escherichia coli used in the high-throughput screening method according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011581900.1A CN112680498A (en) | 2020-12-28 | 2020-12-28 | High-throughput screening method for genotoxic substances |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011581900.1A CN112680498A (en) | 2020-12-28 | 2020-12-28 | High-throughput screening method for genotoxic substances |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112680498A true CN112680498A (en) | 2021-04-20 |
Family
ID=75454307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011581900.1A Pending CN112680498A (en) | 2020-12-28 | 2020-12-28 | High-throughput screening method for genotoxic substances |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112680498A (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07155188A (en) * | 1993-12-06 | 1995-06-20 | Chisso Corp | Nitro reductase gene |
JPH08131176A (en) * | 1994-11-07 | 1996-05-28 | Chisso Corp | Escherichia coli nitro reductase gene |
CN1880461A (en) * | 2006-04-28 | 2006-12-20 | 清华大学 | Escherichia coli self-cracking method and its dedicated carrier and application |
CN1880460A (en) * | 2006-04-28 | 2006-12-20 | 清华大学 | Escherichia coli self-cracking method and its dedicated carrier and application |
JP2006340723A (en) * | 2006-08-01 | 2006-12-21 | Vlaams Instelling Voor Technologisch Onderzoek (Vito) | Recombinant nucleic acid sequence and method for measuring both genetic toxicity and mutagenicity of sample and rate of genetic toxicity |
CN102965368A (en) * | 2012-07-27 | 2013-03-13 | 中国科学院水生生物研究所 | Super-sensitive yeast genotoxic carcinogen biosensor element box and its application |
US20150140123A1 (en) * | 2012-06-13 | 2015-05-21 | Merck Patent Gmbh | Protein expression analyses for identifying genotoxic compounds |
CN106636164A (en) * | 2017-01-18 | 2017-05-10 | 华南理工大学 | Genetic toxicant detection vector and detection method |
CN106906209A (en) * | 2017-03-09 | 2017-06-30 | 华南理工大学 | A kind of DNA damage detects response element and its application |
CN110873790A (en) * | 2018-09-03 | 2020-03-10 | 华南理工大学 | Whole-cell biosensor for detecting heavy metal ions in water-soluble sample and construction and application thereof |
-
2020
- 2020-12-28 CN CN202011581900.1A patent/CN112680498A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07155188A (en) * | 1993-12-06 | 1995-06-20 | Chisso Corp | Nitro reductase gene |
JPH08131176A (en) * | 1994-11-07 | 1996-05-28 | Chisso Corp | Escherichia coli nitro reductase gene |
CN1880461A (en) * | 2006-04-28 | 2006-12-20 | 清华大学 | Escherichia coli self-cracking method and its dedicated carrier and application |
CN1880460A (en) * | 2006-04-28 | 2006-12-20 | 清华大学 | Escherichia coli self-cracking method and its dedicated carrier and application |
JP2006340723A (en) * | 2006-08-01 | 2006-12-21 | Vlaams Instelling Voor Technologisch Onderzoek (Vito) | Recombinant nucleic acid sequence and method for measuring both genetic toxicity and mutagenicity of sample and rate of genetic toxicity |
US20150140123A1 (en) * | 2012-06-13 | 2015-05-21 | Merck Patent Gmbh | Protein expression analyses for identifying genotoxic compounds |
CN102965368A (en) * | 2012-07-27 | 2013-03-13 | 中国科学院水生生物研究所 | Super-sensitive yeast genotoxic carcinogen biosensor element box and its application |
CN106636164A (en) * | 2017-01-18 | 2017-05-10 | 华南理工大学 | Genetic toxicant detection vector and detection method |
CN106906209A (en) * | 2017-03-09 | 2017-06-30 | 华南理工大学 | A kind of DNA damage detects response element and its application |
CN110873790A (en) * | 2018-09-03 | 2020-03-10 | 华南理工大学 | Whole-cell biosensor for detecting heavy metal ions in water-soluble sample and construction and application thereof |
Non-Patent Citations (4)
Title |
---|
YOSHIMITSU ODA等: "Highly Sensitive umu Test System for the Detection of Mutagenic Nitroarenes in Salmonella typhimurium NM3009 Having High 0-Acetyltransferase and Nitroreductase Activities", 《ENVIRONMENTAL AND MOLECULAR MUTAGENESIS》 * |
YOSHIMITSU ODA等: "Use of a High-Throughput umu-Microplate Test System for Rapid Detection of Genotoxicity Produced by Mutagenic Carcinogens and Airborne Particulate Matter", 《ENVIRONMENTAL AND MOLECULAR MUTAGENESIS》 * |
YOSHIMITSUODA等: "Development of high sensitive umu test system: rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity", 《MUTATION RESEARCH/ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS》 * |
郝召等: "生物样品体外致突变高通量检测方法研究进展", 《应用与环境生物学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lassak et al. | ArcS, the cognate sensor kinase in an atypical Arc system of Shewanella oneidensis MR-1 | |
Porsby et al. | Phaeobacter and Ruegeria species of the Roseobacter clade colonize separate niches in a Danish turbot (Scophthalmus maximus)-rearing farm and antagonize Vibrio anguillarum under different growth conditions | |
CN106164265A (en) | Psicose epimerase and the method using its production psicose | |
Cerna-Vargas et al. | Chemoperception of specific amino acids controls phytopathogenicity in Pseudomonas syringae pv. tomato | |
Young et al. | Amplification of the respiratory NADH dehydrogenase of Escherichia coli by gene cloning | |
Zhu et al. | Identification and characterization of trimethylamine N‐oxide (TMAO) demethylase and TMAO permease in M ethylocella silvestris BL 2 | |
Sánchez et al. | The nitrate‐sensing N as ST system regulates nitrous oxide reductase and periplasmic nitrate reductase in B radyrhizobium japonicum | |
Jie et al. | A set of shuttle plasmids for gene expression in Acinetobacter baumannii | |
Pickering et al. | The twin arginine transport system appears to be essential for viability in Sinorhizobium meliloti | |
CN109337886A (en) | Fumonisin degrading enzyme FumDXA and its gene and application | |
Lemaire et al. | Shewanella decolorationis LDS1 chromate resistance | |
Li et al. | Xanthomonas campestris sensor kinase HpaS co‐opts the orphan response regulator VemR to form a branched two‐component system that regulates motility | |
CN113430181B (en) | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof | |
Witte et al. | Functional prokaryotic RubisCO from an oceanic metagenomic library | |
WO2024045796A1 (en) | Cyclodextrin glucosyltransferase with improved solvent tolerance and preparation thereof | |
CN111117942B (en) | Genetic engineering bacterium for producing lincomycin and construction method and application thereof | |
CN112680498A (en) | High-throughput screening method for genotoxic substances | |
CN110452895B (en) | Lysozyme from bacteriophage and gene and application thereof | |
Huo et al. | Identifying amino acid overproducers using rare-codon-rich markers | |
Ge et al. | Comparative genomics analysis of Bacillus velezensis LOH112 isolated from a nonagenarian provides insights into its biocontrol and probiotic traits | |
Chen et al. | The GacA-GacS type two-component system modulates the pathogenicity of Dickeya oryzae EC1 mainly by regulating the production of zeamines | |
CN111118037A (en) | Gene DICX4 with herbicide dicamba degradation function and application thereof | |
CN111607575B (en) | Transaminase PHTA, preparation method and application | |
Ward et al. | An ABC transporter plays a developmental aggregation role in Myxococcus xanthus | |
CN114081120A (en) | Preparation of lactobacillus copper-rich oxidase and application of lactobacillus copper-rich oxidase in degradation of biogenic amine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |